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A characteristic feature of Staphylococcus aureus is its ability to acquire resistance to
antimicrobial agents. There is a need, therefore, for new approaches to combat this
pathogen; for example, employing a combination of plant-derived products and antibiotics
to overcome bacterial resistance. Indigofera suffruticosa is a plant popularly used to treat
infections and has verified antimicrobial action. Here, we investigate the antimicrobial
activity of different extracts from I. suffruticosa against S. aureus and their synergistic
effects with erythromycin. Leaves of I. suffruticosa were extracted sequentially using
diethyl ether, chloroform and acetone and the antimicrobial activity of each extract then
tested against nine clinical isolates of S. aureus. Minimal inhibitory concentration (MIC)
and minimal bactericidal concentration (MBC) were determined by microdilution tests,
while the fractional inhibitory concentration (FIC) was assessed by checkerboard assay.
All organic solvent extracts showed antimicrobial activity against S. aureus strains. The
acetone extract was the most potent inhibitor of S. aureus (MIC and MBC of 0.78 and
3.12mg/mL), followed by the chloroform extract (MIC and MBC of 3.12 and 6.25mg/mL).
Furthermore, acetone or chloroform extracts of I. suffruticosa enhanced the activity of
erythromycin against S. aureus (FIC ≤ 0.5). We conclude that organic extracts from leaves
of I. suffruticosa, alone or combined with erythromycin, are promising natural products for
the development of new anti-S. aureus formulations.
Keywords: plant extracts, antibacterial agents, macrolide antibiotic, S. aureus
INTRODUCTION
Patients in hospital intensive care units are at risk of acquiring
nosocomial infections due to the use of invasive devices and/
or extended hospital stay (Streit et al., 2004). Long-term hos-
pitalization may further complicate patient health by exposure
to various antimicrobial agents. Additionally, the indiscriminate
use of antibiotics in treating infections promotes bacterial evo-
lution and emergence of resistance strains (Palmer and Kishony,
2013; Tavares et al., 2013). Staphylococcus aureus is an important
pathogen associated with nosocomial human infections, and this
microorganism has successfully evolved numerous strategies to
resist different antibiotics (Coutinho et al., 2009; Chung et al.,
2011). Such increases in antibiotic resistant S. aureus strains drives
research discovery of new antimicrobial agents and the devel-
opment of alternative therapeutic strategies. These include plant
extracts, which have considerable antimicrobial potential (Leite
et al., 2006; da Silva et al., 2013; Zakavi et al., 2013).
Medicinal plants are important health and economic com-
ponents used by many cultures for thousands of years (Agra
et al., 2008; Silva et al., 2012). According to the World Health
Organization approximately 80% of the global population uses
medicinal plants or herbal medicine for primary health care
(Pereira et al., 2012). Brazil has the highest plant diversity of
any country and represents 20% of biodiversity in the world.
Indigofera suffruticosa Mill (Fabaceae, Papilionidae) is a plant
originally from Antilles and Central America, popularly known
as “anileira” or “anil,” and was introduced into Brazil for the
extraction of indigo, a blue dye blue (Indigo Blue) widely used
by the textile industry. Although some toxic effects are reported
for this plant, such as hemolytic anemia and hemoglobinuria in
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Table 1 | Pharmacological potential of Indigofera suffruticosa.
Scientific account Related compounds
Gastroprotective agent acute ulcer stimulating prostaglandin, mucus and
HSP70. (Luiz-Ferreira et al., 2011)
Ethyl acetate fraction from methanolic extract showed the best action and
the authors highlighted the role of role of flavonoids and alkaloids presents
in AcF as active compounds
In vivo action against Pediculosis capitis (García Calixto et al., 2011) An effective treatment using 5% I. suffruticosa Mill tincture was reported
in a patient infested with Pediculosis capitis
Immunostimulatory and antitumoral actvities in vitro (Lopes et al., 2011) This study evaluated the action of both alkaloid fraction and pure indigo.
Indigo showed high activity which suggest that it is the major active
principle in I. suffruticosa
Antimycobacterial (Carli et al., 2010) These authors did not isolate or detected any compounds. The methanolic
extract showed better activity than dichloromethane
Anticonvulsant effect (Almeida et al., 2013) Alkaloids, flavonoids, steroids, proteins, carbohydrates, indigo carmine and
essential oils (Linalool and Pinene) were detected in the methanolic extract
Anti-inflammatory property in vivo (Chen et al., 2013a) Eight phenolic compounds were quantified: salicylic acid, syringic acid
(major compounds) ρ-coumaric acid, vanillin, syringaldehyde, quercetin,
isoliquiritigenin, formononetin. Salicylic acid was found in the plasma of
mice fed with I. suffruticosa extracts
In vivo increase of Phase II detoxification enzyme and glutathione levels
(Chen et al., 2013b)
The authors reported the same compounds quantified by Chen et al.
(2013a). Ethanolic extracts showed the best action on the induction of
phase II detoxification enzyme, and syringic acid was the most active
among phenolic compounds detected, however, it was less potent than
ethanolic extracts
cattle and guinea pig (Salvador et al., 2011), it has been used in
traditional medicine both externally and internally (Barros and
Teixeira, 2008). Moreover, pharmacological effects of I. suffruti-
cosa have been confirmed scientifically, such as anti-inflammatory
(Chen et al., 2013a), anticonvulant (Almeida et al., 2013) and
wound healing (Luiz-Ferreira et al., 2011) (Table 1). Previous
work by our group has shown that aqueous infusions of I. suf-
fruticosa leaves have inhibitory activity against S. aureus and
dermatophyte strains (fungi) (Leite et al., 2006), though their
action against clinical isolates and synergic potential have yet to be
studied.
Synergistic assessments have become a key tool in phy-
tomedicine research in recent years, and uses of antibiotics
in combination with herbal products have been investigated
as antimicrobials for S. aureus resistant strains (Wagner and
Ulrich-Merzenich, 2009). Some studies have used erythromycin,
a 14-membered ring macrolide antibiotic and therefore part of
the Macrolide-Lincosamide-Streptogramin-B (MLSB) family, as
a representative drug to evaluate combinatory effects of plant-
derived products (Chan et al., 2013, 2015). Antibiotics from the
MLSB family serve as an important combatant against S. aureus
methicillin resistant (MRSA) strains, which are a major cause of
disease in the general population and hospital-acquired infec-
tions (Pantosti, 2012). MLSB comprises three unrelated groups
(macrolide, lincosamide and streptogramin-B) that share the
same binding site in bacterial ribosome. It is possible, therefore,
that a synergistic effect for one group might predict a similar
action from the other groups.
Given this background, our study aimed to define the antimi-
crobial activities of different organic extracts from I. suffruticosa
leaves against S. aureus strains (MRSA and MSSA), and then to
examine synergistic actions with erythromycin.
MATERIALS AND METHODS
CHEMICALS
Dimethylsulfoxide (DMSO), erythromycin and 7-hydroxy-
3H-phenoxazin-3-one-10-oxide sodium salt (Resazurin) was
purchased from Sigma-Aldrich Chemical Company, St. Louis,
MO, while Mueller-Hinton Agar and Nutrient Agar medium
were from HIMEDIA Laboratories®. Diethylether, chloro-
form and acetone were obtained from Merck, Darmstadt,
Germany.
PLANT MATERIAL AND PREPARATION OF ORGANIC EXTRACTS
Leaves of I. suffruticosa were collected in São Caetano,
Pernambuco, Brazil (latitude: 08◦ 19′ 33′′ S; longitude: 36◦ 04′
21′′ W) between 10 and 11 a.m. The plant was identified by
Dr. Marlene Carvalho Alencar Barbosa (Department of Botany,
UFPE) and a voucher specimen deposited at the UFP Geraldo
Mariz Herbarium-UFPE (identification number 45.217).
Organic extracts were prepared by successively extracting dried
leaves of I. suffruticosa (100 g) with 200mL of diethyl ether,
chloroform or acetone, common solvents arranged in order of
increasing polarity. Briefly, the leaf powder was homogenized
firstly with 200mL of diethyl ether for 2 h in a mechanical stir-
rer, kept refrigerated overnight (4◦C) and filtered with Whatman
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no.1 paper. The solvent was then removed under reduced pressure
in a rotary evaporator at 45◦C to produce diethyl ether extract.
The plant material which was not extracted by diethyl ether was
then homogenized with 200mL chloroform and all extraction
process was repeated generating the chloroform extract. Finally,
the remaining powder was submitted to acetone extraction to
produce acetone extract. All dried organic extracts of I. suffru-
ticosa were stored at −20◦C until use and dissolved in dimethyl
sulfoxide (DMSO, 1%) before each test.
PHYTOCHEMICAL SCREENING
An approximate amount of diethyl ether, chloroform and ace-
tone extracts from I. suffruticosa leaves were subjected to phy-
tochemical analysis to ascertain the presence of secondary
metabolites such as alkaloids, flavonoids, phenylpropanoids,
triterpenoids and volatile oil in according to Wagner and
Bladt (2009). Briefly, compounds classes were visualized as
aid thin layer chromatography (TLC) on silicagel 60 F254
(Merck), mobile phase standard and Dragendorff, NEU-PEG,
KOH-Ethanol, Liebermann-Burchard and vanillin-sulfuric acid
reagents, respectively. Tests for tannins, saponins and other het-




The antimicrobial activity was tested against the following
microorganisms provided by the Departamento de Antibióticos,
Universidade Federal de Pernambuco (UFPEDA): Staphylococcus
aureus (UFPEDA 02), and some isolated strains of S. aureus orig-
inally obtained from: vaginal secretion (UFPEDA 660); catheter
tip (UFPEDA 663); urine sample (UFPEDA 670); blood sam-
ple (UFPEDA 672); prostate secretion (UFPEDA 676); wound
secretion (UFPEDA 677 and 679); ocular secretion (UFPEDA
687). Strains UFPEDA 670 and 672 are classified as MRSA strains
(Table 2). All strains were and maintained in Mueller-Hinton
Agar (MHA) and stored at 4◦C.
Table 2 | Susceptibility to antibiotics of Staphylococcus aureus
strainsa.
UFPEDA Source Susceptibility to antibiotics
Oxacillin Cefoxitin Erythromycin Clindamycin
02 ATCC 6538 S S S S
660 Vaginal secretion S S S S
663 Catheter tip S S S S
670b Urine sample R R R R
672b Blood sample R R R R
676 Prostate secretion S S S S
677 Wound secretion S R R S
679 Wound secretion S S R S
687 Ocular secretion S S S S
R, resistant; S, sensitive. aData provided by UFPEDA Collection. bMRSA.
Determination of antibacterial activity using the disc diffusion
method
The antibacterial activity of the organic extracts of I. suffruticosa
leaves was determined by the disc diffusion method (de Oliveira
et al., 2012). Briefly, all clinically isolated S. aureus strains were
grown on MHA medium at 37◦C for 18 h, suspended in distilled
water (approximately 1.5 × 108 CFU/mL) and 100μL aliquots of
bacterial suspension were immediately inoculated in Petri dishes
containing MHA medium. Sterile paper discs (6mm diameter)
containing 20μL organic extracts of I. suffruticosa (100mg/mL)
were applied to the agar and the Petri dishes incubated at 37◦C
for an additional 18 h. Following incubation, the diameter of the
inhibition zone (DIZ) of growth was measured, using DMSO as
negative control.
Effects of temperature and pH on antimicrobial activity
The antimicrobial activity of each I. suffruticosa extract against
S. aureus UFPEDA 02 was determined. Samples were placed in
sterile tubes and kept for 30min at different temperatures (28,
30, 60, and 100◦C), or were stored at a different pH for 30min at
25◦C, using 1MNaOH or 1MHCl to adjust the pH range between
3 and 10. The antibacterial activity of treated extracts was tested
using the disc diffusion method, as described above.
Determination of minimum inhibitory concentration (MIC) and
minimum bactericidal concentration (MBC)
The minimal inhibitory concentration (MIC) was determined
by a microdilution broth susceptibility assay (Clinical and
Laboratory Standards Institute, 2011). Two-fold serial dilutions of
the organic extracts of I. suffruticosa containing 50–0.20mg/mL
in DMSO were prepared in Mueller-Hinton Broth (MHB;
200μL) in a 96-well microtiter plate. Bacterial suspensions were
prepared from each S. aureus strains freshly grown in Mueller-
Hinton broth (Merck) (approximately 1.5 × 108 CFU/mL,) and
10μL of this suspension was added to each well. After incubation
at 37◦C for 24 h, bacterial growth was recorded using a Resazurin
solution (0.01%). MIC was the lowest concentration at which no
color change (from purple to pink) was observed. Afterwards,
cultures were seeded in MHA medium and incubated for 24 h
at 37◦C to determine the minimum bactericidal concentration
(MBC), which corresponds to the lowest amount of extract that
kills S. aureus. All experiments were performed in triplicate.
Evaluation of combinatory effects of extracts and erythromycin
Combinatory effects between organic extracts of I. suffruticosa
and erythromycin were assessed using the checkerboard test
against the strain UFPEDA 02. Briefly, samples with different
proportions of plant extract:drug (final volume: 20μL) were
prepared from stock solutions of each extract (50mg/mL) and
erythromycin (1mg/mL) and antibacterial activity was tested
as described for MIC determination (da Silva et al., 2013).
The Fractional Inhibitory Concentration (FIC) was calculated
according to the equation:
FIC = (MICE + D/MICE) + (MICD + E/MICD)
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MICE+D: minimal inhibitory concentration of extract in com-
bination with erythromycin; MICD+E: minimal inhibitory con-
centration of erythromycin in combination with extract. Results
were considered: synergistic (FIC < 0.5); additive (0.5 <
FIC < 1); non-interactive (1 < FIC < 4); or antagonist
(FIC > 4) (Vuuren and Viljoen, 2011).
STATISTICAL ANALYSIS
Each experiment was performed in triplicate and results are
expressed as the mean± standard deviation (SD). Statistical anal-
yses were performed by ANOVA and unpaired Student’s t-test.
All analyses were carried out using software StatView, version 4.5,
Abacus Concept, Inc, Berkeley, CA. Differences were considered
significant at p < 0.05. The correlation indices were calculated
using the Pearson coefficient (ρ).
RESULTS
PHYTOCHEMICAL ANALYSIS
TLC analysis revealed the presence of flavonoids, phenyl-
propanoids, triterpenoids and volatile oils in all three extracts.
Table 3 | Phytochemical analysis of organic extract from leaves of
Indigofera suffruticosa.
Compounds class Indigofera suffruticosa extracts
Ether Chloroform Acetone
Alkaloids - + -
Flavonoids + + ++
Phenylpropanoids ++ + +
Triterpenoids + + +
Volatile oils + ++ +
(-) absent, (+) weak, (++) strong.
Table 4 | Antimicrobial activity of organic extracts from leaves of
Indigofera suffruticosa against Staphylococcus aureus strains.
S. aureus strains Organic extracts of leaves of
Indigofera suffruticosa DIZ
Ether Chloroform Acetone
02 34.7±0.6a,1 36.0±0.0a,1 35.7±1.1a,1
660 29.0±1.7b,1 28.0±2.0b,1 28.0±2.0b,1
663 28.7±0.6b,1 27.7±0.6b,1 26.7±0.6b,1
670 32.7±1.1a,1 27.7±2.5b,2 30.7±0.6b,2
672 32.6±1.1a,1 32.3±0.6c,1 31.0±3.0b,1
676 27.3±0.6b,1 25.3±0.6b,1 26.3±0.6b,1
677 30.0±1.0b,1 29.0±1.7b,1 29.7±0.6b,1
679 29.0±1.0b,1 26.3±2.3b,1 25.7±2.1b,1
687 26.7±2.3b,1 26.0±2.6b,1 25.3±2.1b,1
Average DIZ 30.08±2.7 28.7±3.4 28.78±3.4
DIZ values are expressed in mm.
*Same superscript letter ( a,b,c) indicates no significant difference (p > 0.05)
between DIZ values from different strains for each solvent (same column).
**Same superscript number (1,2) indicates no significant difference (p > 0.05)
between DIZ values from different solvents against each strain (same row).
In most of the tests performed, only quantitative differences
were found. Thus, flavonoids, phenylpropanoids and volatile
oils predominated in acetone, ether and chloroform extracts,
respectively. Alkaloids or nitrogen-containing compounds were
detected only in the chloroform extract of I. suffruticosa (Table 3).
ANTIBACTERIAL ACTIVITY OF ORGANIC EXTRACTS FROM LEAVES OF
I. SUFFRUTICOSA
All organic extracts of leaves of I. suffruticosa showed antimi-
crobial activity against different S. aureus strains. However, the
inhibition varied according to the extract and test strain with
DIZ values ranging from 25.3 ± 2.1 to 36.0 ± 1.0mm (Table 4).
All extracts were active against both MRSA strains (UFPEDA
670 and UFPEDA 672) with DIZ values >30.0mm, except for
the chloroform extract which gave a DIZ of 27.7 ± 2.5mm for
strain UFPEDA 670. Diethyl ether extracts showed the best inhibi-
tion (30.08 ± 2.69mm), followed by acetone (28.79 ± 3.35mm)
and chloroform (28.7 ± 3.42mm), however no significant dif-
ferences were observed between these average DIZ values (p >
0.05). Furthermore, strong correlations were found between the
DIZ of all extracts with ρ-values of 0.86, 0.94, and 0.92 for
ethyl/chloroform, and chloroform/acetone ethyl/acetone extracts,
respectively. The antimicrobial activity of the extracts was not
affected (p > 0.05) after high temperature treatment (Figure 1A)
or variation of pH (Figure 1B), except for the ether extract which
was notably more active at pH 8 (p > 0.05).
FIGURE 1 | Stability of organic extracts of leaves of Indigofera
suffruticosa. (A) Effect of temperature on the stability of organic extracts
of I. suffruticosa. (B) Effect of pH on the stability of organic extracts of I.
suffruticosa. DIZ—inhibition zone diameter. ∗Significant differences in
relation to control.
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Table 5 | Minimum inhibitory concentration and minimum bactericidal concentration of organic extracts from leaves of Indigofera suffruticosa
against Staphylococcus aureus strains.
S. aureus strains Organic extracts from leaves of Indigofera suffruticosa
Ether Chloroform Acetone
MIC MBC MBC/MIC MIC MBC MBC/MIC MIC MBC MBC/MIC
02 3.12 12.5 4 3.12 12.5 4 1.56 3.12 2
660 6.25 12.5 2 6.25 25.0 4 1.56 6.25 4
663 6.25 25.0 4 6.25 25.0 4 3.12 12.5 4
670 6.25 25.0 4 6.25 25.0 4 1.56 12.5 8
672 6.25 12.5 2 6.25 12.5 2 3.12 6.25 2
676 6.25 12.5 2 3.12 12.5 4 3.12 3.12 1
677 6.25 25.0 4 3.12 6.25 2 3.12 6.25 2
679 6.25 12.5 2 3.12 6.25 2 1.56 6.25 4
687 6.25 12.5 2 6.25 12.5 2 0.78 12.5 16
MIC50 6.25 6.25 1.56
MBC50 12.5 12.5 6.25
Average MIC 5.9 ± 1.0 4.85 ± 1.6 2.16 ± 0.9
Average MBC 16.67 ± 6.2 15.27 ± 7.7 7.63 ± 3.8
MIC, minimal inhibitory concentration; MBC, minimal bactericidal concentration.
MIC50, concentration able to inhibit 50% of strains; MBC50, concentration able to kill 50% of strains.
MIC, MIC50, MBC and MBC50 are expressed in mg/mL.
The MIC and MBC values ranged from 0.78 to 6.25mg/mL
and 3.12 to 25.0mg/mL, respectively, with the acetone extract
having the lowest values (Table 5). The MIC50 (minimum con-
centration able to inhibit 50% of strains) was 1.56mg/mL for the
acetone extract, and 6.25mg/ml for both ether and chloroform
extracts. Similarly, the MBC50 (minimum concentration able to
kill 50% of strains), for the acetone extract was 6.25mg/mL,
but 12.5mg/mL for ether and chloroform extracts. Additionally,
the average MIC and MBC of acetone extract (2.16 ± 0.9
and 7.63 ± 3.8, respectively) were lower (p > 0.05) than other
extracts (4.85 ± 1.6 and 15.27 ± 7.7 for ether extract; and
5.9 ± 1.0mg/mL and 16.67 ± 6.2mg/mL for chloroform). The
three extracts also differed in their MBC/MIC ratio (Pankey and
Sabath, 2004); although ether and chloroform extracts showed
exclusively bactericidal effects (MBC/MIC ratios ranged from 2
to 4), the acetone extract had both bactericidal and bacteriostatic
actions, however this extract was a bactericidal agent for almost
all S. aureus strains tested (77.78%).
COMBINATORY EFFECTS OF ORGANIC EXTRACTS OF I. SUFFRUTICOSA
AND ERYTHROMYCIN
When the antimicrobial actions of erythromycin and I. suf-
fruticosa organic extracts were tested in combination, additive,
synergistic and non-interactive actions were observed (Table 6);
importantly, no antagonistic effects were noted. Acetone extract
and erythromycin showed synergistic effects (in five ratios
(55.56%; FIC values ranged from 0.3 to 0.5), additive effects
(0.6 ≤ FIC ≤ 0.8) in three and a non-interactive effect in
only one (ratio of 1:9, drug:extract; FIC = 1.7). For the chlo-
roform extract and erythromycin combinations both synergistic
(0.2 ≤ FIC ≤ 0.4) and additive (0.7 ≤ FIC ≤ 0.9) effects
were equally found in four ratios and only one ratio gave a
Table 6 | Combinatory effects of organic extracts from leaves of
Indigofera suffruticosa and erythromycin against S. aureus
UFPEDA 02.
Erythromycin/ Organic extracts from Indigofera
Extracts proportion suffruticosa leaves (FIC)
Ether Chloroform Acetone
9:1 0.9 0.9 0.4
8:2 0.9 0.4 0.4
7:3 0.7 0.7 0.3
6:4 0.6 0.3 0.6
5:5 0.6 0.2 0.5
4:6 0.8 0.8 0.8
3:7 1.2 0.3 0.3
2:8 0.8 0.8 0.8
1:9 0.8 1.7 1.7
Average FIC 0.81 ± 0.18 0.68 ± 0.46 0.644 ± 0.44
non-interaction (1:9, drug:extract; FIC = 1.7). No synergistic
effect was seen with ether extracts, but 8 ratios resulted in addi-
tive effects (0.6 ≤ FIC ≤ 0.9) and 1 ratio a non-interactive
effect (3:7, drug:extract; FIC = 1.2). Strong correlations were
observed between FIC values from erythromycin/acetone and
erythromycin/chloroform combinations (ρ = 0.82), although no
significant difference was found between the mean of their FIC
values (0.68 ± 0.46 and 0.644 ± 0.44; p < 0.05). The best FIC
values were 0.2 for erythromycin/chloroform at 5:5, followed by
0.3 for all these combinations: erythromycin/acetone (at 7:3 and
3:7) and for erythromycin/chloroform (at 3:7 and 6:4).
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DISCUSSION
S. aureus is a pathogen long-recognized to be capable of develop-
ing drug resistance which increases patient treatment time, rate of
morbidity and mortality, and associated financial costs (Pantosti,
2012). These factors make the search for new active agents against
S. aureus highly relevant. In contrast to the well-known antimi-
crobial effects of I. suffruticosa (Leite et al., 2006; Carli et al.,
2010), our present work is the first to evaluate organic solvent
extracts for activity against clinical isolates of S. aureus strains
(including two MRSA strains), as well their combinatory effects
with a macrolide drug (erythromycin).
The organic extracts from I. suffruticosa leaves showed antimi-
crobial activity against all tested strains of S. aureus and, impor-
tantly, high inhibition zones were found against MRSA strains
(UFPEDA 670 and UFPEDA 672). These two strains were isolated
from different sources and exhibited multidrug-resistant profile
(oxacillin-cefoxitin-erythromycin-clindamycin). The best anti-
S. aureus activity was shown by the acetone extract, since its
MIC50 was 4-fold lower than the MIC50 values of the two other
extracts. From chemical point of view, the acetone extract con-
tains more flavonoids than ether and chloroform extracts. It is
known that different species of genus Indigofera including I. suf-
fruticosa are rich source of bioactive flavonoids (Hasan et al.,
1993; Narender et al., 2006; Varanda et al., 2011; Perez et al.,
2013). Previous chemical analysis from I. suffruticosa resulted
in the identification of four quercetin derivatives. Although our
result revealed that the antimicrobial properties might be associ-
ated with the presence of flavonoids, a characterization of acetone
extract is necessary, even though this has not been our major
focus.
We also showed that high temperature (up to 100◦C) had
negligible effect on the anti-S. aureus activity of each extract,
which may explain the effective traditional usage of I. suffru-
ticosa in infusions prepared by prolonged boiling of its leaves
(Corrêa, 1984). Similarly, the antimicrobial activities of our three
organic extracts showed little change when submitted to pH val-
ues ranging from pH 3 to pH 10. Thermal and pH stabilities are
noteworthy factors for development of new antimicrobial formu-
lations by the cosmetic, food and pharmaceutical industries, and
our findings encourage further research into use of our organic
extracts.
Exploring combinatory effects of antimicrobial agents and
natural products is an attractive strategy to overcome bacte-
rial resistance (Betoni et al., 2006; Wink et al., 2012). Diverse
targets are involved in the synergistic effects of drugs and plant-
derived products such as enzymes and substrates, metabolites,
receptors, ion channels, transport proteins, DNA and RNA
(Wagner, 2011; Yang et al., 2014). Our study establishes that
all organic extracts from I. suffruticosa induce at least addi-
tive effects with erythromycin. In addition to its more potent
antimicrobial activity, the synergestic effect of the acetone extract
was higher than that of the chloroform extract, although this
did not reach statistical significance and the FIC values of
the two were strongly correlated. In contrast, the I. suffru-
ticosa ether extract only showed additive effects or, in one
tested ratio, a non-interactive effect. These results suggest these
as a promising source of potential compounds to be used in
combination of erythromycin (and other members of MLSB
family).
I. suffruticosa extracts have been target of a various studies in
order to prove their medicinal potential. Most of these works have
shown that polar solvent extracts are more active (Table 1) as they
are rich in phenolic compounds, flavonoids, carbohydrates, gly-
coproteins, indigo, alkaloids, and triterpenes (Leite et al., 2006;
Carli et al., 2010; Lopes et al., 2011; Luiz-Ferreira et al., 2011;
Almeida et al., 2013; Chen et al., 2013a,b). Furthermore, extracts
from I. suffruticosa have been also shown key features to be used
as a medicine such as lethal dose 50% (1600mg/kg (ip) in mice
(Almeida et al., 2013) and induction of phase II detoxification
enzyme and increase of glutathione levels in rat Clone 9 liver cells
(Chen et al., 2013b).
In summary this paper showed that organic extracts of I. suf-
fruticosa are promising natural products for the development of
new anti-S. aureus formulation given their antimicrobial inhibit-
ing MRSA strains and their combination with erythromycin
seems to be very perspective, thus deserving further studies in
order to understand their mechanism of action.
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